Pfizer Breakthrough Growth Initiative
Description
Pfizer Breakthrough Growth Initiative provide funding to biotechnology companies.
Investor Profile
Pfizer Breakthrough Growth Initiative has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Post Ipo Equity, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada, Belgium.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Series A (33%)
- Post Ipo Equity (33%)
- Series B (33%)
Country Focus
- United States (33%)
- Canada (33%)
- Belgium (33%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Pharmaceutical
- Biopharma
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Pfizer Breakthrough Growth Initiative frequently co-invest with?
What are some of recent deals done by Pfizer Breakthrough Growth Initiative?
Find More Investors Like Pfizer Breakthrough Growth Initiative
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








